Immediate Impact

1 by Nobel laureates 3 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
3 intermediate papers

Works of Jenna L. Voellinger being referenced

A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML
2018
A Phase 1b Study of Vadastuximab Talirine in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
2016

Author Peers

Author Last Decade Papers Cites
Jenna L. Voellinger 166 83 102 149 11 391
Pedro Caetano-Pinto 160 16 88 119 22 341
Git Chung 156 7 141 62 14 371
Pamela Roper 144 55 100 37 11 348
Shawn M. Heidel 184 23 68 24 11 424
Ganesh Moorthy 180 24 149 27 22 434
Carlos M. Laborde 291 19 47 26 12 457
Jae Hong Seo 179 17 160 39 16 386
Mauro Naturale 96 28 43 20 13 368
Peter Nygren 140 19 181 40 13 393
Yu-Chieh Lee 221 10 54 40 14 358

All Works

Loading papers...

Rankless by CCL
2026